S&P 500   5,055.61 (+1.48%)
DOW   38,859.21 (+0.64%)
QQQ   436.01 (+2.44%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)
S&P 500   5,055.61 (+1.48%)
DOW   38,859.21 (+0.64%)
QQQ   436.01 (+2.44%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)
S&P 500   5,055.61 (+1.48%)
DOW   38,859.21 (+0.64%)
QQQ   436.01 (+2.44%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)
S&P 500   5,055.61 (+1.48%)
DOW   38,859.21 (+0.64%)
QQQ   436.01 (+2.44%)
AAPL   183.07 (+0.41%)
MSFT   411.94 (+2.43%)
META   486.22 (+3.89%)
GOOGL   144.17 (+1.14%)
AMZN   172.99 (+2.61%)
TSLA   192.65 (-1.09%)
NVDA   778.57 (+15.39%)
NIO   5.73 (-4.02%)
AMD   181.36 (+10.39%)
BABA   75.56 (-0.03%)
T   16.61 (-2.29%)
F   12.19 (+0.41%)
MU   85.60 (+5.04%)
CGC   3.41 (-0.87%)
GE   151.26 (+1.47%)
DIS   108.22 (+0.51%)
AMC   4.51 (-1.31%)
PFE   27.24 (-1.55%)
PYPL   57.76 (+0.49%)
XOM   104.62 (-0.22%)

CareDx (CDNA) Competitors

$8.11
-0.13 (-1.58%)
(As of 10:33 AM ET)

CDNA vs. CELC, SERA, CSTL, HHLA, BDSX, FLGT, GTH, BNR, PSNL, and VRDN

Should you be buying CareDx stock or one of its competitors? The main competitors of CareDx include Celcuity (CELC), Sera Prognostics (SERA), Castle Biosciences (CSTL), HH&L Acquisition (HHLA), Biodesix (BDSX), Fulgent Genetics (FLGT), Genetron (GTH), Burning Rock Biotech (BNR), Personalis (PSNL), and Viridian Therapeutics (VRDN). These companies are all part of the "medical" sector.

CareDx vs.

Celcuity (NASDAQ:CELC) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, community ranking, media sentiment, valuation, profitability and analyst recommendations.

Celcuity has a net margin of 0.00% compared to Celcuity's net margin of -30.46%. Celcuity's return on equity of -21.94% beat CareDx's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -49.14% -35.52%
CareDx -30.46%-21.94%-17.35%

63.3% of Celcuity shares are held by institutional investors. 24.3% of Celcuity shares are held by insiders. Comparatively, 4.2% of CareDx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Celcuity currently has a consensus target price of $25.00, suggesting a potential upside of 74.22%. CareDx has a consensus target price of $13.80, suggesting a potential upside of 67.48%. Given CareDx's stronger consensus rating and higher possible upside, equities analysts clearly believe Celcuity is more favorable than CareDx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
CareDx
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, CareDx had 2 more articles in the media than Celcuity. MarketBeat recorded 5 mentions for CareDx and 3 mentions for Celcuity. Celcuity's average media sentiment score of 0.88 beat CareDx's score of 0.00 indicating that CareDx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareDx
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CareDx received 103 more outperform votes than Celcuity when rated by MarketBeat users. Likewise, 66.51% of users gave CareDx an outperform vote while only 66.25% of users gave Celcuity an outperform vote.

CompanyUnderperformOutperform
CelcuityOutperform Votes
318
66.25%
Underperform Votes
162
33.75%
CareDxOutperform Votes
421
66.51%
Underperform Votes
212
33.49%

Celcuity has higher earnings, but lower revenue than CareDx. Celcuity is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$40.37M-$2.73-5.26
CareDx$297.14M1.50-$76.61M-$1.67-4.93

Celcuity has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500. Comparatively, CareDx has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500.

Summary

CareDx beats Celcuity on 11 of the 17 factors compared between the two stocks.


Get CareDx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDNA vs. The Competition

MetricCareDxMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$445.23M$1.89B$4.97B$7.37B
Dividend YieldN/A1.88%2.91%3.86%
P/E Ratio-4.934.7895.3014.70
Price / Sales1.5054.303,262.61154.77
Price / CashN/A8.1389.1453.45
Price / Book1.023.304.284.56
Net Income-$76.61M-$139.28M$112.46M$207.29M
7 Day Performance-3.06%-2.64%0.71%-0.95%
1 Month Performance-16.00%4.04%5.96%3.18%
1 Year Performance-41.18%-17.05%7.25%3.35%

CareDx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELC
Celcuity
1.7863 of 5 stars
$15.03
-5.9%
$25.00
+66.3%
+25.8%$363.73MN/A-5.5145Analyst Report
News Coverage
Gap Up
SERA
Sera Prognostics
0.9056 of 5 stars
$8.52
-4.2%
$2.75
-67.7%
+183.2%$267.02M$270,000.00-6.9887News Coverage
CSTL
Castle Biosciences
1.4688 of 5 stars
$23.06
-6.3%
$31.38
+36.1%
+4.0%$620.55M$137.04M-8.12587Upcoming Earnings
HHLA
HH&L Acquisition
0 of 5 stars
$10.75
-0.3%
N/A+5.2%$156.52MN/A-76.78N/A
BDSX
Biodesix
3.1292 of 5 stars
$1.58
-4.2%
$3.50
+121.5%
-36.5%$142.96M$38.21M-1.76245Gap Down
FLGT
Fulgent Genetics
4.6205 of 5 stars
$24.91
-4.8%
$36.00
+44.5%
-21.2%$738.08M$618.97M-11.641,012Upcoming Earnings
News Coverage
GTH
Genetron
0 of 5 stars
$3.81
+0.3%
N/A+32.6%$120.47M$94.34M0.00993News Coverage
BNR
Burning Rock Biotech
0 of 5 stars
$0.82
+2.5%
N/A-69.7%$84.18M$81.66M-0.841,138Gap Up
PSNL
Personalis
4.3828 of 5 stars
$1.19
-11.2%
$4.93
+314.6%
-59.0%$58.35M$65.05M-0.50395Positive News
Gap Down
VRDN
Viridian Therapeutics
1.7414 of 5 stars
$17.74
-9.9%
$37.80
+113.1%
-42.9%$932.95M$1.77M-3.4886Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:CDNA) was last updated on 2/22/2024 by MarketBeat.com Staff